11/19
07:20 am
adtx
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. [Yahoo! Finance]
Medium
Report
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. [Yahoo! Finance]
11/14
04:44 pm
adtx
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 [Yahoo! Finance]
High
Report
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 [Yahoo! Finance]
11/14
04:36 pm
adtx
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Medium
Report
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
11/14
07:28 am
adtx
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]
Low
Report
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]
11/14
07:20 am
adtx
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Yahoo! Finance]
Low
Report
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Yahoo! Finance]
11/14
07:15 am
adtx
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Low
Report
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
11/8
08:30 am
adtx
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
Medium
Report
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
11/7
08:30 am
adtx
Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
High
Report
Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
11/6
07:28 pm
adtx
Appili Therapeutics Announces Results of Special Meeting of Shareholders [Canadian Business Journal (Canada)]
High
Report
Appili Therapeutics Announces Results of Special Meeting of Shareholders [Canadian Business Journal (Canada)]
11/6
06:00 pm
adtx
Appili Therapeutics Announces Results of Special Meeting of Shareholders [Yahoo! Finance]
High
Report
Appili Therapeutics Announces Results of Special Meeting of Shareholders [Yahoo! Finance]
11/6
08:30 am
adtx
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
Medium
Report
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
11/6
08:00 am
adtx
Evofem Secures Investor Support for Proposed Merger through Voting Agreements
Medium
Report
Evofem Secures Investor Support for Proposed Merger through Voting Agreements
10/31
08:30 am
adtx
Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
Medium
Report
Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
10/31
07:23 am
adtx
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission [Yahoo! Finance]
Medium
Report
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission [Yahoo! Finance]
10/31
07:20 am
adtx
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission [Financial Post (Toronto, Ontario, Canada)]
High
Report
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission [Financial Post (Toronto, Ontario, Canada)]
10/31
07:15 am
adtx
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
Medium
Report
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
10/30
05:00 pm
adtx
Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
Low
Report
Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
10/29
08:15 am
adtx
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
High
Report
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
10/28
08:15 am
adtx
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
High
Report
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
10/21
08:15 am
adtx
Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time
Low
Report
Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time
10/13
08:07 am
adtx
Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy [Yahoo! Finance]
Medium
Report
Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy [Yahoo! Finance]
10/10
03:47 pm
adtx
Appili Therapeutics – Press Release Correction [Yahoo! Finance]
Medium
Report
Appili Therapeutics – Press Release Correction [Yahoo! Finance]
10/10
03:47 pm
adtx
Appili Therapeutics – Press Release Correction [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Appili Therapeutics – Press Release Correction [Financial Post (Toronto, Ontario, Canada)]
10/10
08:15 am
adtx
Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
Medium
Report
Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
10/10
07:23 am
adtx
Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]